No deals were found in the last 365 days.
No deals were found in the last 365 days.
| Notifier | Holding | Value* |
|---|---|---|
| Carolyn Cross | 156,314,029 | £21,493,179 |
| Nicolas Loebel | 3,538,991 | £486,611 |
| Junaid Bajwa | 1,193,697 | £164,133 |
| Jean Duvall | 1,163,529 | £159,985 |
| Jean Charest | 353,356 | £48,586 |
| Notifier** | Holding | Value* |
|---|---|---|
| Carolyn Cross | 120,161,319 | £16,522,181 |
| M&G Plc | 74,268,775 | £10,211,957 |
| hInsight-NX, LLC | 42,272,654 | £5,812,490 |
| Robert Cross | 37,772,652 | £5,193,740 |
| Albemarle Life Sciences Fund | 15,105,882 | £2,077,059 |
| CRUX Asset Management | 9,298,090 | £1,278,487 |
| Chelverton Asset Management | 7,957,311 | £1,094,130 |
| Currency | UK Pounds |
| Share Price | 13.75p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 18.00 |
| 52 Week Low | 8.00 |
| Volume | 110,428 |
| Shares Issued | 561.22m |
| Market Cap | £77.17m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:42 | 50,000 @ 13.50p |
| 14:26 | 21 @ 14.00p |
| 14:21 | 14 @ 14.00p |
| 10:53 | 25,000 @ 13.56p |
| 10:36 | 30,623 @ 13.75p |
| Chair | Jean Charest |
| CEO | Carolyn Cross |
You are here: research